Sanofi Pasteur

189 articles with Sanofi Pasteur

• Sanofi Pasteur Release: High-Dose Influenza Vaccine Recognized As A New Option With Demonstrated Superior Efficacy* For Adults 65 Years And Older

  2/24/2016

• The Human Vaccines Project Welcomes Sanofi Pasteur To Its Global Consortium

  1/15/2016

• Sanofi Pasteur's Dengue Vaccine Approved in the Philippines

  12/22/2015

• Sanofi Pasteur to Launch World's First Dengue Vaccine in Mexico

  12/10/2015

• Sanofi Pasteur Proposes Expansion that Will Create 100 New Jobs in Pennsylvania

  11/17/2015

• Infectious Disease Research Institute (IDRI) And Sanofi Pasteur Team With Philanthropy To Develop New Model For Vaccine Development

  10/15/2015

• Dyadic International, Inc. Receives C1 Derived Vaccine Test Results From Sanofi Pasteur And Provides Further Details On New EU-Funded ZAPI Biopharmaceutical Program

  10/7/2015

• Sanofi Pasteur Release: New Analysis Reports Lower Rates Of Serious Cardio-Respiratory Events Among Study Participants Administered Higher-Dose Influenza Vaccine

  8/3/2015

• Sanofi Pasteur Ships First 2015-2016 Seasonal Influenza Vaccine Doses In United States

  7/14/2015

• VBI Vaccines Announces Research Collaboration With Sanofi Pasteur To Enhance Vaccine Stability

  4/7/2015

• Sanofi Pasteur Announces FDA Approval Of Quadracel Dtap-IPV Vaccine For Children 4 Through 6 Years Of Age

  3/25/2015

• EXCLUSIVE: Sanofi Pasteur US CMO Says U.S. Regulators Most Interested in Four-Strain Flu Vax

  12/18/2014

• Sanofi Pasteur Announces FDA Approval Of Fluzone Intradermal Quadrivalent (Influenza Vaccine) For Adults

  12/12/2014

• Sanofi Pasteur's Investigational Dengue Vaccine Hits Main Goal Showing Efficacy In Phase 3 Trial

  11/4/2014

• Sanofi Pasteur Announces FDA Approval Of Updated Prescribing Information For Fluzone® High-Dose Vaccine For Adults 65 And Older

  11/3/2014

• FDA Accepts For Review A Biologics License Application For Merck & Co. And Sanofi Pasteur’s Investigational Pediatric Hexavalent Vaccine

  10/20/2014

• Sanofi Pasteur And Immune Design Corporation Enter Broad Collaboration For The Development Of A Herpes Simplex Virus Therapy

  10/16/2014

• Sanofi Pasteur Release: FDA Approves Use Of Menactra® Vaccine For Booster Immunization Against Potentially Deadly Disease

  9/9/2014

• Sanofi Pasteur Touts Positive Trial Data For Fluzone High-Dose Vaccine

  8/14/2014

• Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine For Upcoming 2014-2015 Season In United States

  7/22/2014